These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38647258)

  • 1. Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization.
    Su Y; Li S; Li X; Zhou JY; Chauhan VP; Li M; Su YH; Liu CM; Ren YF; Yin W; Rimer JD; Cai T
    Adv Sci (Weinh); 2024 Jun; 11(21):e2400642. PubMed ID: 38647258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
    PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium phosphate controls nucleation and growth of calcium oxalate crystal phases in kidney stones.
    Michibata U; Maruyama M; Tanaka Y; Yoshimura M; Yoshikawa H; Takano K; Furukawa Y; Momma K; Tajiri R; Taguchi K; Hamamoto S; Okada A; Kohri K; Yasui T; Usami S; Imanishi M; Mori Y
    Biomed Res; 2024; 45(3):103-113. PubMed ID: 38839353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Chem Soc; 2003 Mar; 125(10):2854-5. PubMed ID: 12617634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Pathways for the Molecular Step Growth of Calcium Oxalate Monohydrate Crystal Revealed by In Situ Liquid-Phase Atomic Force Microscopy.
    Cho KR; Lee JH; Seo HS; Ji Y; Park JH; Lee SE; Kim HW; Wu KJJ; Kulshreshtha P
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):37873-37882. PubMed ID: 34327985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
    Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
    J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
    Noonin C; Peerapen P; Yoodee S; Kapincharanon C; Kanlaya R; Thongboonkerd V
    Chem Biol Interact; 2022 Apr; 357():109879. PubMed ID: 35263610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-grade Garcinia cambogia extract dissolves calcium oxalate crystals in Drosophila kidney stone models.
    Fan QX; Gong SQ; Hong XZ; Feng XM; Zhang FJ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6434-6445. PubMed ID: 32572941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.
    Sheng X; Jung T; Wesson JA; Ward MD
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):267-72. PubMed ID: 15625112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of macromolecules in the formation of kidney stones.
    Rimer JD; Kolbach-Mandel AM; Ward MD; Wesson JA
    Urolithiasis; 2017 Feb; 45(1):57-74. PubMed ID: 27913854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential bound proteins and adhesive capabilities of calcium oxalate monohydrate crystals with various sizes.
    Peerapen P; Thongboonkerd V
    Int J Biol Macromol; 2020 Nov; 163():2210-2223. PubMed ID: 32956748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting urinary calcium oxalate crystallization with inulin-type AOFOS from Aspidopterys obcordata Hemsl. for the management of rat urolithiasis.
    Sun P; Yue J; Lu C; Ji K; Yang R; Lu J; Song X; Hu H; Zhao J; Yang Y; Xu Y
    J Ethnopharmacol; 2024 Jul; 329():118149. PubMed ID: 38580188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.
    Qiu SR; Wierzbicki A; Salter EA; Zepeda S; Orme CA; Hoyer JR; Nancollas GH; Cody AM; De Yoreo JJ
    J Am Chem Soc; 2005 Jun; 127(25):9036-44. PubMed ID: 15969581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of crystal surface adhesion in kidney stone disease.
    Wesson JA; Ward MD
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):386-93. PubMed ID: 16775453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.